IMATINIB vs PALBOCICLIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
IMATINIB vs PALBOCICLIB: Safety Overview
| Metric | IMATINIB | PALBOCICLIB |
|---|---|---|
| Total FAERS Reports | 43,161 | 91,024 |
| Deaths Reported | 13,761 | 11,066 |
| Death Rate | 31.9% | 12.2% |
| Hospitalizations | 7,264 | 13,442 |
| Average Patient Age | 55.7 yrs | 66.0 yrs |
| % Female Patients | 47.2% | 97.7% |
| FDA Approval Date | Apr 14, 2025 | Feb 3, 2015 |
| Manufacturer | Dr.Reddy's Laboratories Inc | Pfizer Laboratories Div Pfizer Inc |
| Route | ORAL | ORAL |
| Marketing Status | Discontinued | Prescription |